507 related articles for article (PubMed ID: 31103587)
1. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
3. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
4. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
Kammerlander AA; Marzluf BA; Zotter-Tufaro C; Aschauer S; Duca F; Bachmann A; Knechtelsdorfer K; Wiesinger M; Pfaffenberger S; Greiser A; Lang IM; Bonderman D; Mascherbauer J
JACC Cardiovasc Imaging; 2016 Jan; 9(1):14-23. PubMed ID: 26684970
[TBL] [Abstract][Full Text] [Related]
5. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
7. Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
Al-Wakeel-Marquard N; Rastin S; Muench F; O H-Ici D; Yilmaz S; Berger F; Kuehne T; Messroghli DR
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1961-1968. PubMed ID: 28620681
[TBL] [Abstract][Full Text] [Related]
8. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
9. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage.
Schelbert EB; Piehler KM; Zareba KM; Moon JC; Ugander M; Messroghli DR; Valeti US; Chang CC; Shroff SG; Diez J; Miller CA; Schmitt M; Kellman P; Butler J; Gheorghiade M; Wong TC
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26683218
[TBL] [Abstract][Full Text] [Related]
11. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
[TBL] [Abstract][Full Text] [Related]
12. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
Fontana M; White SK; Banypersad SM; Sado DM; Maestrini V; Flett AS; Piechnik SK; Neubauer S; Roberts N; Moon JC
J Cardiovasc Magn Reson; 2012 Dec; 14(1):88. PubMed ID: 23272651
[TBL] [Abstract][Full Text] [Related]
13. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
[TBL] [Abstract][Full Text] [Related]
16. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis.
Backhaus SJ; Lange T; Beuthner BE; Topci R; Wang X; Kowallick JT; Lotz J; Seidler T; Toischer K; Zeisberg EM; Puls M; Jacobshagen C; Uecker M; Hasenfuß G; Schuster A
J Cardiovasc Magn Reson; 2020 Jun; 22(1):46. PubMed ID: 32564773
[TBL] [Abstract][Full Text] [Related]
17. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
Dolan RS; Stillman AE; Davarpanah AH
Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
[TBL] [Abstract][Full Text] [Related]
20. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
